Wenyi Wei

66PUBLICATIONS
172CO-AUTHORS
Cancer diagnosisBiologically active moleculesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (66)

|Jul 11, 2026
Linking deubiquitination to pyroptosis: new perspectives from OTUB1 in hepatocellular carcinoma.

|May 05, 2026
Discovery of New OTUB1 Covalent Ligands via Structure-Activity Relationship Studies for Targeted Protein Stabilization.

|Apr 03, 2026
Aberrant amino acid-sensing promotes immunotherapy resistance via the inflammatory cytokine-ZBTB5-mTORC1 axis.

Junyu Xiang, Tao Wang, Shuoran Tian

|Mar 26, 2026
Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications.

Sharmin Akter, Rajesh Madhuvilakku, Anik Kumar Kar

|Jan 14, 2026
CD47 destabilization via manipulating the SPOP-USP2 axis augments macrophage phagocytosis and cancer immunotherapy.

Peiqiang Yan, Xia Bu, Tao Hou

|Nov 12, 2025
Targeted destruction of VISTA boosts anti-tumor immunotherapy.

Li Chen, Xia Bu, Yishuang Sun

Pageof 11

Frequent Collaborators

16 joint publications

Jian Jin

12 joint publications

Jinfang Zhang

11 joint publications

Jing Liu

7 joint publications

Gordon J Freeman